Fundraising FoxPagari Life Science
Bethalta, US · Founded 2022 · Delaware corporation
Find your way into Pagari Life Science
Sign up to see every warm intro you have to Pagari Life Science
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Pagari Life Science team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
SP
Stephen PeipertExecutive
JW
James WickenhauserExecutiveJames Wickenhauser is Chief Operating Officer at Pagari Life Science, which develops a healing and pain management platform. He holds an MBA from Gies College of Business and brings over two decades of operations and business development experience across biotechnology, healthcare, and manufacturing sectors.
DF
David FeldkerExecutiveDavid Feldker has held leadership roles at biotech companies of varying sizes, including experience securing both debt and equity financing for a smaller organization.
AW
Alan WickenhauserNamed on SEC filing
SP
Stephen PiepertNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$678K disclosed across 4 rounds · 2023–2026
▶$97.5KraisedMay 2026 · 8 investors · PharmaceuticalsRule 506(b)
▶$97.5KraisedMay 2026 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- James WickenhauserExecutive Officer
- Marni ZenkewiczExecutive Officer
- David FeldkerExecutive Officer, Director
- Stephen PeipertExecutive Officer, Director
- Offering amount
- $300K
- Amount sold
- $97.5K
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$55.5KraisedMay 2025 · 6 investors · PharmaceuticalsRule 506(b)
▶$55.5KraisedMay 2025 · 6 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Stephen PeipertExecutive Officer, Director
- James WickenhauserExecutive Officer
- Marni ZenkewiczExecutive Officer
- David FeldkerExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $55.5K
- First sale
- May 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$275KraisedApr 2024 · 2 investors · PharmaceuticalsRule 506(b)
▶$275KraisedApr 2024 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Marni ZenkewiczExecutive Officer
- James WickenhauserExecutive Officer
- David FeldkerExecutive Officer, Director
- Stephen PeipertDirector
- Alan WickenhauserDirector
- Offering amount
- $600K
- Amount sold
- $275K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$250KraisedOct 2023 · 3 investors · Other Health CareRule 506(b)
▶$250KraisedOct 2023 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marni ZenkewiczExecutive Officer
- David FeldkerDirector
- Alan WickenhauserDirector
- Stephen PiepertDirector
- James WickenhauserExecutive Officer
- Offering amount
- $450K
- Amount sold
- $250K
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Pagari Life Science raised?
- Pagari Life Science has disclosed $678K raised across 4 rounds.
- Where is Pagari Life Science headquartered?
- Pagari Life Science is headquartered in Bethalta, US.